NEIDL Researchers Collaborate on AI-Driven Approach to Identify Potential New Ebola Drug Targets
NEIDL researchers have found a new method to identify human genes that, when silenced, impair the Ebola virus’s ability to infect host cells.
NEIDL Researcher Wins a 2024 Kilachand Fund Award
What if we could find a way to bring mRNA vaccines and antibodies together, so each retains their benefits while reducing their limitations? A new Boston University project aims to do just that.
Inside the Insectary: How BU Scientists Study Diseases from Mosquitoes—without Getting Bitten
Original article from The Brink by Devin Hahn & Andrew…
BU Scientists Are Prepared to Detect Omicron—and Other Variants
Original article from The Brink By Kat J. McAlpine. December…
Malaria Vaccine—the First Ever to Immunize against a Parasitic Infection—Gets Green Light from WHO (Q&A w/ Davidson Hamer)
Original article from The Brink By Jessica Colarossi. October 7,…
Myths vs. Facts: Making Sense of COVID-19 Vaccine Misinformation
Original article from The Brink By Doug Most. August 13,…
Study Reveals Recipe for Even More Powerful COVID-19 Vaccines
Original article from The Brink by Kat J. McAlpine. June…
Study provides novel platform to study how SARS-CoV-2 affects the gut
Original article from Medical XPress by BU School of Medicine….
A 2020 Pandemic Year in Review: BUSM Steps Up
Original article from BU School of Medicine by Sara Frazier….
Dressed For Success; GMS students join the early fight against COVID-19
Original article from Boston University Medicine by Art Jahnke. Winter…